Severe Hepatotoxicity of Telithromycin

  1. Joseph S. Bertino, PharmD
  1. From the Ordway Research Institute, Albany, New York.

    TO THE EDITOR:

    Although Clay and colleagues' article on possible telithromycin-induced hepatic toxicity was of interest (1), some clarifications are needed. In case 1, the authors report that the patient presented with a 4-day history of dark urine, jaundice, and malaise …

    This 100-word excerpt has been provided in the absence of an abstract.

    Summary for Patients

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement